A new AI framework that can help doctors build better tools

Artificial intelligence can help predict a patient's risk for conditions such as sepsis, heart disease and cancer. But many of these tools fall short in real-life clinical practice because they are difficult for doctors to ...

FDA expands use of kidney cancer drug belzutifan

Belzutifan, a first-in-class drug that arose from scientific discoveries at UT Southwestern Medical Center, has been approved by the Food and Drug Administration to treat some patients with earlier-stage kidney cancers in ...

Researcher finds gender gap in kidney transplant referrals

Female patients with kidney failure are significantly less likely to be referred to a transplant center for assessment, according to a new study from ICES, London Health Sciences Center Research Institute (LHSCRI) and Western ...

page 2 from 29